Literature DB >> 88745

Aranucleosides and aranucleotides in viral chemotherapy.

T W North, S S Cohen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 88745     DOI: 10.1016/0163-7258(79)90016-0

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  19 in total

Review 1.  Role of Marine Natural Products in the Genesis of Antiviral Agents.

Authors:  Vedanjali Gogineni; Raymond F Schinazi; Mark T Hamann
Journal:  Chem Rev       Date:  2015-08-28       Impact factor: 60.622

2.  Reduced in vivo mutagenesis by mutant herpes simplex DNA polymerase involves improved nucleotide selection.

Authors:  J D Hall; P A Furman; M H St Clair; C W Knopf
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

3.  Effect of combinations of acyclovir with vidarabine or its 5'-monophosphate on herpes simplex viruses in cell culture and in mice.

Authors:  R F Schinazi; J Peters; C C Williams; D Chance; A J Nahmias
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

4.  Susceptibility of phosphonoformic acid-resistant herpes simplex virus variants to arabinosylnucleosides and aphidicolin.

Authors:  K F Bastow; D D Derse; Y C Cheng
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

5.  Fine mapping and molecular cloning of mutations in the herpes simplex virus DNA polymerase locus.

Authors:  D M Coen; D P Aschman; P T Gelep; M J Retondo; S K Weller; P A Schaffer
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

6.  Evaluation of prodrugs of 9-beta-D-arabinofuranosyladenine for therapeutic efficacy in the topical treatment of genital herpesvirus infections in guinea pigs.

Authors:  W M Shannon; G Arnett; D C Baker; S D Kumar; W I Higuchi
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

7.  Aphidicolin resistance in herpes simplex virus type I reveals features of the DNA polymerase dNTP binding site.

Authors:  J D Hall; Y S Wang; J Pierpont; M S Berlin; S E Rundlett; S Woodward
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

8.  Erythro-9-(2-hydroxy-3-nonyl) Adenine alone and in combination with 9-beta-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in mice.

Authors:  W M Shannon; G Arnett; F M Schabel; T W North; S S Cohen
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

9.  Comparison of the efficacy of vidarabine, its carbocyclic analog (cyclaradine), and cyclaradine-5'-methoxyacetate in the treatment of herpes simplex virus type 1 encephalitis in mice.

Authors:  W M Shannon; L Westbrook; G Arnett; S Daluge; H Lee; R Vince
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

10.  Mutations in the herpes simplex virus DNA polymerase gene can confer resistance to 9-beta-D-arabinofuranosyladenine.

Authors:  D M Coen; P A Furman; P T Gelep; P A Schaffer
Journal:  J Virol       Date:  1982-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.